TMEM64 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.162000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.999600E-01
Normal-vs-Stage2
3.552200E-01
Normal-vs-Stage3
3.782400E-01
Normal-vs-Stage4
8.599000E-01
Stage1-vs-Stage2
4.894400E-01
Stage1-vs-Stage3
3.546400E-01
Stage1-vs-Stage4
9.344600E-01
Stage2-vs-Stage3
5.567600E-01
Stage2-vs-Stage4
4.744200E-01
Stage3-vs-Stage4
3.743400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.131400E-01
Normal-vs-AfricanAmerican
9.701400E-01
Normal-vs-Asian
1.149230E-01
Caucasian-vs-AfricanAmerican
2.831600E-01
Caucasian-vs-Asian
2.196600E-01
AfricanAmerican-vs-Asian
6.473700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.263200E-01
Normal-vs-Female
4.275000E-01
Male-vs-Female
5.894600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.211800E-01
Normal-vs-Age(41-60Yrs)
6.699400E-01
Normal-vs-Age(61-80Yrs)
3.700800E-01
Normal-vs-Age(81-100Yrs)
1.656180E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.048000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.958200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.437400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.089240E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.496400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.140200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.072600E-01
Normal-vs-Daily Drinker
1.239600E-01
Normal-vs-Weekly Drinker
6.799000E-01
Normal-vs-Occasional Drinker
5.560000E-01
Normal-vs-Social Drinker
6.249000E-01
Non Drinker-vs-Daily Drinker
4.507400E-01
Non Drinker-vs-Weekly Drinker
4.273200E-01
Non Drinker-vs-Occasional Drinker
5.112200E-01
Non Drinker-vs-Social Drinker
5.971200E-01
Daily Drinker-vs-Weekly Drinker
2.293000E-01
Daily Drinker-vs-Occasional Drinker
1.939840E-01
Daily Drinker-vs-Social Drinker
3.446000E-01
Weekly Drinker-vs-Occasional Drinker
8.551000E-01
Weekly Drinker-vs-Social Drinker
8.569800E-01
Occasional Drinker-vs-Social Drinker
9.770400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.849800E-01
Normal-vs-Grade 2
9.465400E-01
Normal-vs-Grade 3
8.554200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.948600E-01
Grade 1-vs-Grade 3
6.361000E-01
Grade 1-vs-Grade 4
9.849800E-01
Grade 2-vs-Grade 3
9.292200E-01
Grade 2-vs-Grade 4
9.465400E-01
Grade 3-vs-Grade 4
8.554200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.951800E-01
Normal-vs-NonDiabetic
2.960400E-01
Diabetic-vs-NonDiabetic
9.225600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.459800E-02
Normal-vs-NoPancreatitis
3.760000E-01
Pancreatitis-vs-NoPancreatitis
7.178200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.932200E-01
Normal-vs-N1
3.829600E-01
N0-vs-N1
9.848600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.159200E-01
Normal-vs-TP53-NonMutant
6.409400E-01
TP53-Mutant-vs-TP53-NonMutant
2.483800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
